Back to
GOLDMAN SACHS GROUP INC
NKTR
Showing 4 of 13 quarters
Position history for
GOLDMAN SACHS GROUP INC's holdings in NEKTAR THERAPEUTICS
As of its Q1 2025 13F, Goldman Sachs Group held 531,362 shares of NKTR (Nektar Therapeutics), worth $361,326. Goldman Sachs Group's 13F filings listed NKTR from Q2 2022 to Q1 2025, 12 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$2.3M
Total Shares Change
-1.8M
Quarter-by-Quarter History